{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:18:35Z","timestamp":1777540715583,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.brainres.2008.06.042","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T16:08:50Z","timestamp":1214237330000},"page":"93-102","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice"],"prefix":"10.1016","volume":"1231","author":[{"given":"Luciana Maria","family":"dos Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azair","family":"Canto-de-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brainres.2008.06.042_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02246192","article-title":"Naloxone blocks the antianxiety but not the effects of benzodiazepines and pentobarbital \u2014 experimental studies and literature","volume":"120","author":"Agmo","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pnpbp.2005.01.010","article-title":"A comparative study with two types of elevated plus-maze (transparent vs, opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia","volume":"29","author":"Albrechet-Souza","year":"2005","journal-title":"Prog. in Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2008.06.042_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(84)90488-6","article-title":"Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action","volume":"103","author":"Audi","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2008.06.042_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0091-3057(82)90260-X","article-title":"Benzodiazepine effects upon Geller\u2013Seifter conflict test in rats: analysis of individual variability","volume":"17","author":"Babbini","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.physbeh.2005.04.007","article-title":"Effect of different illumination levels on rat behavior in the elevated plus-maze","volume":"85","author":"Becerra-Garcia","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-4328(99)00148-5","article-title":"Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety","volume":"108","author":"Bertoglio","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0091-3057(02)00958-9","article-title":"Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze","volume":"73","author":"Bertoglio","year":"2002","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-4328(01)00396-5","article-title":"Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal\/nocturnal phases and under different illumination conditions","volume":"132","author":"Bertoglio","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(02)00710-4","article-title":"Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze","volume":"72","author":"Bertoglio","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-003-1558-z","article-title":"Anxiolytic-like effects of NMDA\/glicine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats","volume":"170","author":"Bertoglio","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2005.03.010","article-title":"Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats","volume":"162","author":"Bertoglio","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"suppl.","key":"10.1016\/j.brainres.2008.06.042_bib12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0278-5846(89)90105-X","article-title":"Attack and defense in rodents as ethoexperimental models for the study of emotion","volume":"13","author":"Blanchard","year":"1989","journal-title":"Prog. in Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2008.06.042_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-3057(82)90441-5","article-title":"GABA mediation of antiaversive action of minor tranquilizers","volume":"16","author":"Brand\u00e3o","year":"1982","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0006-8993(01)03354-6","article-title":"Anxiolytic-like effect of WAY-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience","volume":"928","author":"Canto-de-Souza","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","article-title":"Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on","volume":"29","author":"Carobrez","year":"2005","journal-title":"Neurosci. biobehav. rev."},{"key":"10.1016\/j.brainres.2008.06.042_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-199312000-00003","article-title":"An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus maze","volume":"4","author":"Cole","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","article-title":"Ethopharmacological analysis of rat behavior on the elevated plus-maze","volume":"49","author":"Cruz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0091-3057(02)00813-4","article-title":"One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat","volume":"72","author":"Cruz-Morales","year":"2002","journal-title":"Pharmacol. Biochem. Behav.r"},{"key":"10.1016\/j.brainres.2008.06.042_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF02245242","article-title":"One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure","volume":"113","author":"Dawson","year":"1994","journal-title":"Psycopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib20","doi-asserted-by":"crossref","unstructured":"De Boer, S.F., Koolhaas, J.M., 2003. Defensive burying in rodents: ethology, neurobiology and psychopharmacology 463, 145\u2013161.","DOI":"10.1016\/S0014-2999(03)01278-0"},{"key":"10.1016\/j.brainres.2008.06.042_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0091-3057(95)02171-X","article-title":"The influence of open arm ledges and maze experience in the elevated plus-maze","volume":"54","author":"Fernandes","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/026988110101500203","article-title":"Interactions between LY354740, a group II metabotropic agonist and the GABA(A)\u2013benzodiazepine receptor complex in the rat elevated plus-maze","volume":"15","author":"Ferris","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02244419","article-title":"One-trial tolerance to the anxiolytic effects of benzodiazepines in the plus-maze","volume":"100","author":"File","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib24","series-title":"Experimental Approaches to Anxiety and Depression","first-page":"25","article-title":"Behavioural detection of anxiolytic action","author":"File","year":"1992"},{"key":"10.1016\/j.brainres.2008.06.042_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0166-4328(93)90103-W","article-title":"The interplay of learning and anxiety in the elevated plus-maze","volume":"58","author":"File","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25 years of the interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF02246980","article-title":"One-trial tolerance to the anxiolytic actions of the benzodiazepines in the elevated plus-maze, or the development of a phobic state?","volume":"110","author":"File","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02245751","article-title":"Characterization of phenomenon of \u201cone-trial tolerance\u201d to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze","volume":"102","author":"File","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib29","series-title":"The Mouse Brain in Stereotaxic Coordinates. Ed.","author":"Franklin","year":"1997"},{"key":"10.1016\/j.brainres.2008.06.042_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1523\/JNEUROSCI.17-04-01505.1997","article-title":"A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus","volume":"17","author":"Gonzalez","year":"1997","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2008.06.042_bib32","first-page":"811","article-title":"Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals","volume":"27","author":"Graeff","year":"1994","journal-title":"Braz. J. Med. and Biol. Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0166-4328(86)90061-6","article-title":"Modulation of the brain aversive system by GABAergic and serotonergic mechanisms","volume":"21","author":"Graeff","year":"1986","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2008.06.042_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","article-title":"Role of the amygdala and periaqueductal gray in anxiety and panic","volume":"58","author":"Graeff","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008877-199206000-00010","article-title":"Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats","volume":"3","author":"Green","year":"1992","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.brainres.2008.06.042_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02246664","article-title":"The use of the rat plus-maze to discriminate non-selective and BZ-1 (w1) selective, benzodiazepine receptor ligands","volume":"124","author":"Griebel","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-3057(96)00402-9","article-title":"Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the elevated plus-maze","volume":"57","author":"Griebel","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib38","series-title":"Serotonin, Sleep and Mental Disorder","first-page":"89","article-title":"Serotonin in animal models of anxiety: the importance of stimulus and response","author":"Handley","year":"1991"},{"key":"10.1016\/j.brainres.2008.06.042_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model of \u201cfear\u201d-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0278-5846(00)00151-2","article-title":"The mouse light\u2013dark paradigm: a review","volume":"25","author":"Hasco\u00ebt","year":"2001","journal-title":"Prog. Neuro-Psychophamacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2008.06.042_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and reliability of the elevated plus-maze as a model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0091-3057(98)00008-2","article-title":"Responses of Swiss\u2013Webster mice to repeated plus-maze experience: further evidence for qualitative shift in emotional state?","volume":"60","author":"Holmes","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0149-7634(99)00030-5","article-title":"Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus maze","volume":"23","author":"Holmes","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2008.06.042_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ddr.430190105","article-title":"Effects of buspirone in the Geller\u2013Seifter conflict test with incremental shock","volume":"19","author":"Howard","year":"2004","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/290514a0","article-title":"Selective antagonists of benzodiazepines","volume":"290","author":"Hunkeler","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainres.2008.06.042_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02245837","article-title":"Effects of SB 2006464, a 5-HT2C 5-HT2B receptor antagonist, in 2 conflict models of anxiety","volume":"118","author":"Kennett","year":"1995","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.brainres.2008.06.042_bib47","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0028-3908(98)00115-4","article-title":"Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated","volume":"37","author":"Kennett","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib48","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0028-3908(91)90021-3","article-title":"Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice","volume":"30","author":"Lee","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0149-7634(98)00056-6","article-title":"Effects of centrally administered anxiolytic compounds in animal models of anxiety","volume":"23","author":"Menard","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2008.06.042_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2005.04.026","article-title":"Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice","volume":"1047","author":"Mendes-Gomes","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(87)90005-0","article-title":"GABA\u2013benzodiazepine modulation of aversion in the medial hypothalamus of the rat","volume":"28","author":"Milani","year":"1987","journal-title":"Pharmacol. Biochem. and Behav."},{"issue":"2","key":"10.1016\/j.brainres.2008.06.042_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog.Neurobiol."},{"key":"10.1016\/j.brainres.2008.06.042_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0091-3057(93)90288-5","article-title":"Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test","volume":"44","author":"Motta","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.brainres.2008.06.042_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s002130000428","article-title":"Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam","volume":"150","author":"Nunes-de-Souza","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(01)03335-2","article-title":"Effects of intra-hippocampal infusion of WAY-1000635 on plus-maze behavior in mice. Influence of site of injection and prior test experience.","volume":"927","author":"Nunes-de-Souza","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib76","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2008.06.042_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(94)90662-9","article-title":"The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines","volume":"638","author":"Pesold","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(94)01318-C","article-title":"The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines","volume":"671","author":"Pesold","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(95)01359-8","article-title":"The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam","volume":"710","author":"Pesold","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.06.042_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","article-title":"Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats","volume":"514","author":"Pietraszek","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.06.042_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor-analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"2","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02245704","article-title":"Influence of prior maze experience on behavior and response to diazepam in the elevated plus-maze and light\/dark tests of anxiety in mice","volume":"113","author":"Rodgers","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0091-3057(95)02156-6","article-title":"Plus-maze retest profile: importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade in mice","volume":"54","author":"Rodgers","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0091-3057(96)00134-7","article-title":"Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine","volume":"57","author":"Rodgers","year":"1997","journal-title":"II. The elevated plus-maze. Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0091-3057(00)00316-6","article-title":"Temporal analysis of the rat's behavior in the plus-maze: effect of midazolam","volume":"67","author":"Rosa","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02246973","article-title":"Role of benzodiazepine receptors located in the dorsal periaqueductal gray of rats in anxiety","volume":"110","author":"Russo","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pbb.2004.07.013","article-title":"Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and \u03b2-CCt","volume":"79","author":"Savic","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2003.10.015","article-title":"Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests","volume":"996","author":"Shah","year":"2004","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2008.06.042_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0091-3057(96)00460-1","article-title":"Tolerance to the anticonflict effects of diazepam: importance of methodological considerations","volume":"58","author":"Smith","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF00181234","article-title":"Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?","volume":"90","author":"Stephens","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib72","series-title":"5-HT1A Agonists, 5-HT3 Agonists and Benzodiazepines: Their Comparative Behavioural Pharmacology","first-page":"107","article-title":"Anxiolytic effects of benzodiazepines and 5-HT1A agonists: a review","author":"Treit","year":"1991"},{"key":"10.1016\/j.brainres.2008.06.042_bib73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","article-title":"Anxiogenic stimuli in the elevated plus-maze","volume":"44","author":"Treit","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.06.042_bib74","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02245647","article-title":"Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze","volume":"104","author":"Wada","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2008.06.042_bib75","first-page":"2453","article-title":"Behavioural effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze","volume":"27","author":"Zangrossi","year":"1994","journal-title":"Braz. J. Med. Biol Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308014789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308014789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T08:33:44Z","timestamp":1557650024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899308014789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":76,"alternative-id":["S0006899308014789"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2008.06.042","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}